2019 INTERNATIONAL LEVUCELL SB TECHNICAL MEETING, Institut Pasteur, Paris
On October 23rd, 130 swine professionals from 30 countries around the world gathered at Institut Pasteur in Paris for the Special edition of Lallemand Animal Nutrition International Levucell SB meeting. For this special edition, ten international experts occupied the stage, combining inspirational lectures on topics such as sow behavior around farrowing, mycotoxins in pigs, immunity, or brain-gut microbiota communication with technical presentations on the latest findings about the live yeast modes of action and applied testimonials from various markets, including China, Colombia, and Spain.
During the past decade, pig production has tremendously evolved and the industry has had to adapt to face issues linked to sow hyperprolificacy while antimicrobial usage reduction has become a worldwide concern within the “one health” context.
Fifteen years ago, LEVUCELL SB (Saccharomyces cerevisiae boulardii CNCM I-1079) usage was in its early days in swine, and the research and development journey was just starting. Today, from sow to piglets – and now on to fattening pigs – , the live yeast concept and applications of S. cerevisiae boulardii CNCM I-1079 benefit from sound science, with documented benefits along the whole production cycle1. This special meeting was the occasion to look back at the ten past editions and look into the future for this approach which remains more relevant than ever.
Participants appreciated the good balance between technical information, forward-looking science and more applied, commercial-oriented results, such as neonatal diarrhea management strategies.
David Saornil, Product Manager – Swine Applications, Lallemand Animal Nutrition, commented: “We were very proud to host this special edition of our International Levucell SB meeting, in such an inspiring location as Institut Pasteur, the late home of Louis Pasteur, the father of microbiology! We have come a long way over the past decade and the outlook for future research is bright, thanks to important research and development commitment from Lallemand, and access to new techniques such as OMICS as well as the development on in vivo and in vitro models, that are enabling us to explore new applications to address the markets issues of today and tomorrow”.
For more information, you can contact us for a complete report of the meeting.
1 Since May 2019, S. cerevisiae boulardii CNCM I-1079 is authorized in all stages of pig production cycle in the European Union (EU) (Regulation (EU) No. 2019/892 and Regulation (EU) No. 2018/347